Potent synergistic effect of doxycycline with fluconazole against Candida albicans is mediated by interference with iron homeostasis.

Antimicrobial Agents and Chemotherapy
Alessandro Fiori, Patrick Van Dijck

Abstract

Doxycycline was found to act synergistically with the antifungal fluconazole against Candida albicans. Combination with doxycycline converts fluconazole from fungistatic to fungicidal, prevents the onset of drug resistance, and is also effective against a clinical isolate characterized by elevated resistance to fluconazole. Investigation of the interactions between the two drugs by way of checkerboard assays indicated that doxycycline had an influence on the MIC for fluconazole, as defined by CLSI standards, only at high concentrations (200 μg/ml). However, lower concentrations were effective at eliminating residual cell growth at supra-MICs of fluconazole. Using MIC-0, defined as a drug combination resulting in optically clear wells, as an endpoint, doxycycline was found to be synergistic with fluconazole at a concentration as low as 25 μg/ml, with a fractional inhibitory concentration index of <0.5. Doxycycline-mediated growth inhibition can be reversed by externally added iron, indicating that iron depletion may account for the synergism. Consistently, we confirmed old literature data about iron-chelating activity of doxycycline. Synergism of fluconazole with doxycycline does not appear to be mediated by calcineurin, since d...Continue Reading

References

Aug 1, 1986·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·F C OddsP F Troke
Nov 1, 1993·Biochemical Society Transactions·S L KellyD E Kelly
May 1, 1993·Molecular & General Genetics : MGG·S StettlerP Thuriaux
Nov 14, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K A MarrR A Bowden
Sep 17, 1998·The Journal of Antimicrobial Chemotherapy·L W KitchenS P Day
Feb 11, 1999·Advances in Dental Research·M L Nelson
Mar 3, 1999·The Journal of Antimicrobial Chemotherapy·S MaesakiS Kohno
Oct 30, 1999·Antimicrobial Agents and Chemotherapy·D P KontoyiannisK D Hirschi
Aug 22, 2000·Antimicrobial Agents and Chemotherapy·O MarchettiD Sanglard
Oct 4, 2000·Physiological Reviews·F Rusnak, P Mertz
May 31, 2001·Microbiology and Molecular Biology Reviews : MMBR·I Chopra, M Roberts
Feb 16, 2002·The EMBO Journal·M Cristina CruzJoseph Heitman
Jun 21, 2002·Methods in Enzymology·Fred Sherman
Jun 27, 2002·Biochimica Et Biophysica Acta·Joachim Morschhäuser
Dec 3, 2002·Nature Reviews. Genetics·Judith Berman, Peter E Sudbery
Mar 29, 2003·Diagnostic Microbiology and Infectious Disease·Emilia CantónAna Espinel-Ingroff
Jun 14, 2003·The Journal of Antimicrobial Chemotherapy·F C Odds
Feb 26, 2004·Antimicrobial Agents and Chemotherapy·Melissa D JohnsonJohn H Rex
Mar 26, 2004·Yeast·Caroline J BarelleAlistair J P Brown
Sep 25, 2004·Molecular Microbiology·Chung-Yu LanNina Agabian
May 13, 2005·Methods in Molecular Medicine·Erika J Ernst
Aug 10, 2005·Eukaryotic Cell·Yang-Nim Park, Joachim Morschhäuser
Aug 17, 2005·PLoS Genetics·Burkhard R BraunAndré Nantel
May 26, 2006·Antimicrobial Agents and Chemotherapy·Sergey V BalashovDavid S Perlin
Jan 16, 2007·Clinical Microbiology Reviews·M A Pfaller, D J Diekema

❮ Previous
Next ❯

Citations

Aug 27, 2013·Current Genetics·Lotte Mathé, Patrick Van Dijck
May 22, 2013·Antimicrobial Agents and Chemotherapy·Michael D LafleurKim Lewis
Jun 14, 2015·Expert Review of Anti-infective Therapy·Kaat De CremerKatrijn De Brucker
May 21, 2013·Revista iberoamericana de micología·Florencio ÁlvarezJosé María Aguado
Dec 23, 2015·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Eric Delarze, Dominique Sanglard
Apr 25, 2014·Virulence·Qiu-Rong XuYuan-Ying Jiang
Jul 28, 2016·Microbial Pathogenesis·Khadar Syed MusthafaSupayang Piyawan Voravuthikunchai
Jul 28, 2016·Virulence·Arielle ButtsP David Rogers
Sep 7, 2016·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Andrew J Ghio
Oct 4, 2016·Future Microbiology·Elvira RománJesús Pla
May 16, 2018·Annals of the New York Academy of Sciences·Jennifer Geddes-McAlister, Rebecca S Shapiro
Dec 6, 2017·Antimicrobial Agents and Chemotherapy·Yaolin ChenMalcolm Whiteway
Feb 21, 2019·Antimicrobial Agents and Chemotherapy·Liesbeth DemuyserPatrick Van Dijck
Oct 28, 2019·Current Topics in Medicinal Chemistry·Laura Nunes SilvaAndré Luis Souza Dos Santos
Jan 8, 2020·Antimicrobial Agents and Chemotherapy·Derek C K ChanLori L Burrows
Nov 12, 2019·Metallomics : Integrated Biometal Science·Elizabeth W Hunsaker, Katherine J Franz
Apr 8, 2020·Antimicrobial Agents and Chemotherapy·Lujuan GaoTongxiang Zeng
Mar 20, 2019·Dalton Transactions : an International Journal of Inorganic Chemistry·Elizabeth W Hunsaker, Katherine J Franz
Jul 8, 2017·BioMed Research International·Wisam AlhamadiHussam W Al-Humadi
Nov 9, 2019·Scientific Reports·Rodrigo F M de AlmeidaRadosław Starosta
Jun 21, 2018·Frontiers in Cellular and Infection Microbiology·Ruan FourieCarolina H Pohl

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.